Total submissions: 8
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Laboratory for Molecular Medicine, |
RCV000037258 | SCV000060915 | likely benign | not specified | 2012-03-02 | criteria provided, single submitter | clinical testing | p.Asp312Ala in exon 5 of DES: This variant is not expected to have clinical sign ificance because it has been identified in 0.3% (11/3738) of African American ch romosomes from a broad population by the NHLBI Exome Sequencing Project (http:// evs.gs.washington.edu/EVS; dbSNP rs148947510). |
Gene |
RCV000725547 | SCV000235785 | uncertain significance | not provided | 2024-07-25 | criteria provided, single submitter | clinical testing | Identified in individuals with HCM, DCM, or sudden unexplained death in published literature; however, several individuals harbored additional cardiogenetic variants (PMID: 23785128, 24503780, 27930701, 30847666); In silico analysis supports that this missense variant has a deleterious effect on protein structure/function; This variant is associated with the following publications: (PMID: 24503780, 27930701, 29926427, 17325244, 30847666, 26807690, 23785128, 34935411) |
Ambry Genetics | RCV000243219 | SCV000319576 | likely benign | Cardiovascular phenotype | 2020-10-13 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Eurofins Ntd Llc |
RCV000725547 | SCV000337681 | uncertain significance | not provided | 2017-11-13 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV001085666 | SCV000562348 | likely benign | Desmin-related myofibrillar myopathy | 2024-01-28 | criteria provided, single submitter | clinical testing | |
Athena Diagnostics | RCV000725547 | SCV001475075 | uncertain significance | not provided | 2022-11-03 | criteria provided, single submitter | clinical testing | Available data are insufficient to determine the clinical significance of the variant at this time. The frequency of this variant in the general population is higher than would generally be expected for pathogenic variants in this gene. (http://gnomad.broadinstitute.org) Computational tools predict that this variant is damaging. |
Revvity Omics, |
RCV000725547 | SCV003829031 | uncertain significance | not provided | 2022-11-01 | criteria provided, single submitter | clinical testing | |
Prevention |
RCV003914934 | SCV004732230 | likely benign | DES-related disorder | 2022-09-20 | no assertion criteria provided | clinical testing | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). |